SE460761B - Fenetanolaminer med beta 712-agonistverkan och med topisk antiinflammatorisk effekt, deras foerfarande foer framstaellning samt kompositioner innefattande dessa foereningar - Google Patents

Fenetanolaminer med beta 712-agonistverkan och med topisk antiinflammatorisk effekt, deras foerfarande foer framstaellning samt kompositioner innefattande dessa foereningar

Info

Publication number
SE460761B
SE460761B SE8401181A SE8401181A SE460761B SE 460761 B SE460761 B SE 460761B SE 8401181 A SE8401181 A SE 8401181A SE 8401181 A SE8401181 A SE 8401181A SE 460761 B SE460761 B SE 460761B
Authority
SE
Sweden
Prior art keywords
compound
formula
group
hydrogen
integer
Prior art date
Application number
SE8401181A
Other languages
English (en)
Swedish (sv)
Other versions
SE8401181L (sv
SE8401181D0 (sv
Inventor
W T Comer
X Nair
H R Roth
Jr D L Temple
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/575,418 external-priority patent/US4540581A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8401181D0 publication Critical patent/SE8401181D0/xx
Publication of SE8401181L publication Critical patent/SE8401181L/xx
Publication of SE460761B publication Critical patent/SE460761B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8401181A 1983-03-04 1984-03-02 Fenetanolaminer med beta 712-agonistverkan och med topisk antiinflammatorisk effekt, deras foerfarande foer framstaellning samt kompositioner innefattande dessa foereningar SE460761B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47197683A 1983-03-04 1983-03-04
US06/575,418 US4540581A (en) 1984-01-31 1984-01-31 Topical nonsteroidal anti-inflammatory compositions and uses

Publications (3)

Publication Number Publication Date
SE8401181D0 SE8401181D0 (sv) 1984-03-02
SE8401181L SE8401181L (sv) 1984-09-05
SE460761B true SE460761B (sv) 1989-11-20

Family

ID=27043623

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8401181A SE460761B (sv) 1983-03-04 1984-03-02 Fenetanolaminer med beta 712-agonistverkan och med topisk antiinflammatorisk effekt, deras foerfarande foer framstaellning samt kompositioner innefattande dessa foereningar

Country Status (8)

Country Link
AU (1) AU570671B2 (da)
CA (1) CA1235662A (da)
CH (1) CH659067A5 (da)
DE (1) DE3407861A1 (da)
DK (1) DK140684A (da)
FR (1) FR2541999B1 (da)
GB (1) GB2135883B (da)
SE (1) SE460761B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8609331D0 (en) * 1986-04-16 1986-05-21 Pfizer Ltd Anti-arrythmia agents
EG18188A (en) * 1986-05-01 1992-09-30 Pfizer Ltd Process for preparation anti-arhythmia agents
JP3100165B2 (ja) * 1994-11-29 2000-10-16 大日本製薬株式会社 インドール誘導体
FR2788770B1 (fr) * 1999-01-21 2001-02-16 Oreal Nouveaux 2-sulfonylaminophenols cationiques, leur utilisation a titre de coupleur pour la teinture d'oxydation, compositions les comprenant et procedes de teinture
CN1349502A (zh) * 1999-04-01 2002-05-15 旭化成株式会社 经由叠氮化物制备三环氨基－醇衍生物的新方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB993584A (da) * 1962-01-24
US4138581A (en) * 1969-04-01 1979-02-06 Sterling Drugs Inc. 3(Hydroxy or hydroxymethyl)-4(hydroxy)-α-(aminomethyl)benzyl alcohols
NO129903B (da) * 1969-04-01 1974-06-10 Sterling Drug Inc
US3801631A (en) * 1972-02-16 1974-04-02 Mead Johnson & Co 2'-hydroxy-5'-(1-hydroxy-2-(2-methyl-1-phenyl-2-propylamino)ethyl)meth-anesulfonanilide and its salts
US3919424A (en) * 1972-02-16 1975-11-11 Mead Johnson & Co Bronchodilator process and composition
US3993776A (en) * 1973-10-15 1976-11-23 Mead Johnson & Company Anorexigenic process and composition
GB2077102A (en) * 1980-06-09 1981-12-16 Bristol Myers Co Ophthalmic compositions

Also Published As

Publication number Publication date
FR2541999A1 (fr) 1984-09-07
GB2135883A (en) 1984-09-12
DE3407861A1 (de) 1984-09-06
GB2135883B (en) 1987-10-21
GB8405487D0 (en) 1984-04-04
SE8401181L (sv) 1984-09-05
CA1235662A (en) 1988-04-26
DK140684A (da) 1984-09-05
CH659067A5 (de) 1986-12-31
AU570671B2 (en) 1988-03-24
SE8401181D0 (sv) 1984-03-02
DK140684D0 (da) 1984-02-29
AU2524084A (en) 1984-09-06
FR2541999B1 (fr) 1986-09-19

Similar Documents

Publication Publication Date Title
CA2075876C (fr) Nouveaux derives d'arylethylamines, leurs procedes de preparation et lescompositions pharmaceutiques qui les contiennent
JP4490911B2 (ja) β−２アゴニストとしてのインドール誘導体
EP2079747B1 (en) Heterocyclic compounds useful as anabolic agents for livestock animals
US4234595A (en) 3-Indolyl-tertiary butylaminopropanols
JP4685243B2 (ja) ピリミド［６，１−ａ］イソキノリン−４−オン誘導体
JP2002501041A (ja) カリウムチャネル阻害剤
JP2002537373A (ja) 強力なバニロイド受容体アゴニストおよび鎮痛剤としてのレジニフェラトキシンファーマコフォアを含むバニロイド同類体、その組成物およびその用途
JPS6254095B2 (da)
JPS5922696B2 (ja) フエニルエチルアミン誘導体及びその酸付加塩の製法
JPS61207374A (ja) 新規化合物および医薬組成物
JPS638935B2 (da)
JP2572115B2 (ja) 抗増殖剤として有用な５−アミノ又は置換アミノ−１，２，３− トリアゾール類
JPH0873438A (ja) 中枢神経作用性の新規なベンズイミダゾール系医薬組成物
SE460761B (sv) Fenetanolaminer med beta 712-agonistverkan och med topisk antiinflammatorisk effekt, deras foerfarande foer framstaellning samt kompositioner innefattande dessa foereningar
EP0213984A1 (fr) Nouveaux dérivés de l'indole carboxamide, leurs sels, procédé et intermédiaires de préparation, application à titre de médicaments et compositions les renfermant
JP2001521510A (ja) ガンおよびａｉｄｓの処置のための活性化ヨード誘導体
US6174918B1 (en) Naphthoquinone antitumor compound and method
EP0420120B1 (en) Optically active benzyl alcohol compound and pharmaceutical composition
Du et al. Design, synthesis, and LFA-1/ICAM-1 antagonist activity evaluation of Lifitegrast analogues
US4355045A (en) Anti-inflammatory 1-phenylethanolamine derivatives pharmaceutical compositions thereof and processes for their manufacture
JPS59116269A (ja) イソカルボスチリル誘導体
DE69410198T2 (de) Cyclohexanderivate als Kaliumkanalaktivatoren
EP0367944A2 (en) Ether derivative of 4-[3H] -quinazolinone, a process for the preparation thereof, and pharmaceutical compositions
JP4819770B2 (ja) アドレナリン受容体として有用なホルムアミド誘導体
BE899069A (fr) Phenethanolamines et leurs utilisations

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8401181-6

Effective date: 19921005

Format of ref document f/p: F